Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH [Phase 2, Phase 3]

View source ↗

Summary

This multicenter, randomized, double-blind, placebo-controlled trial evaluated three dose strengths of pulsatile GnRH for infertility and has completed Phase 2/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Pulsatile GnRH (Gonadotropin-releasing hormone)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: InFertility | Phase 2, Phase 3 | Status: COMPLETED